Market Place
Sourcing Support
Oruka Therapeutics To Report ORKA-001 Week 16 Data
26 Apr 2026 //
GLOBENEWSWIRE
Oruka Therapeutics Reports Q4, Full-Year 2025 Results
12 Mar 2026 //
GLOBENEWSWIRE
Oruka Therapeutics Joins Multiple Upcoming Conferences
09 Feb 2026 //
GLOBENEWSWIRE
Oruka Reports Positive ORKA-002 Data, Initiates EVERLAST-B Trial
12 Jan 2026 //
GLOBENEWSWIRE
Oruka Therapeutics Presents at 44th JPM Healthcare Conference
06 Jan 2026 //
GLOBENEWSWIRE
Oruka Therapeutics Reveals Board Member Addition & Transition
11 Dec 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Unveils Q3 2025 Financials & Corporate Update
12 Nov 2025 //
GLOBENEWSWIRE
Oruka Therapeutics To Present at November Investor Conferences
29 Oct 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Reports Positive Interim Phase 1 Results
17 Sep 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Announces $180 Million Private Placement
17 Sep 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Q2 2025 Financial Results and Corporate Update
11 Aug 2025 //
GLOBENEWSWIRE
Oruka Gets IND Clearance for Ph 2a Trial of ORKA-001 in Psoriasis
21 Jul 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Promotes Laura Sandler to COO
01 Jul 2025 //
GLOBENEWSWIRE
Oruka Therapeutics to Present at Jefferies Healthcare Conference
21 May 2025 //
GLOBENEWSWIRE
Oruka Announces 1st Participants Dosed in Ph 1 Trial of ORKA-002
20 May 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Reports Q1 2025 Results and Corporate Update
14 May 2025 //
GLOBENEWSWIRE
Oruka Therapeutics to Present at Bank of America Securities 2025
29 Apr 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Reveals ORKA-002 Preclinical Data at 2025 AAD
07 Mar 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Reports Q4 and Full Year 2024 Results
06 Mar 2025 //
GLOBENEWSWIRE
Oruka Therapeutics To Present At March Investor Conferences
19 Feb 2025 //
GLOBENEWSWIRE
Oruka Therapeutics Doses 1st Participants in ORKA-001 Phase 1 Trial
19 Dec 2024 //
GLOBENEWSWIRE
Oruka Therapeutics Added to Nasdaq Biotechnology Index
18 Dec 2024 //
GLOBENEWSWIRE
Oruka To Present At Piper Sandler’s 36th Healthcare Conference
19 Nov 2024 //
GLOBENEWSWIRE
Oruka Therapeutics Reports Q3 2024 Results & Corporate News
13 Nov 2024 //
GLOBENEWSWIRE
Oruka Therapeutics to Present at Multiple November Investor Conf
04 Nov 2024 //
GLOBENEWSWIRE
Oruka Presents ORKA-001 Preclinical Data At EADV Congress
25 Sep 2024 //
GLOBENEWSWIRE
Oruka Announces ORKA-001 Timelines And EADV Presentation
12 Sep 2024 //
GLOBENEWSWIRE
Oruka Therapeutics Announces $200 Million Private Placement
12 Sep 2024 //
GLOBENEWSWIRE
Oruka Therapeutics Closes Merger with ARCA biopharma, Raises $275 Million
03 Sep 2024 //
GLOBENEWSWIRE
Oruka Therapeutics to Present at the 2024 Jefferies Global Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
03 Apr 2024 //
GLOBENEWSWIRE
Paragon’s hub-and-spoke biotech model yields another reverse merger
03 Apr 2024 //
BIOPHARMADIVE
